Pharmaceuticals
Healthcare
IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain
Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, made a strong debut on the ......
Healthcare
Drug maker Alkem Laboratories files documents for IPO
Alkem Laboratories Ltd, a generic and specialty drug manufacturer, has filed its draft red herring prospectus (DRHP) with securities market ......
Healthcare
Lupin to acquire speciality product portfolio of Germany's Temmler Pharma
Lupin Ltd, India's third-largest drugmaker by sales, has inked an agreement with German-based Temmler Pharma GMBH and CO. KG to ......
Healthcare
Lupin to buy American generic drugmaker GAVIS for $880M in biggest overseas pharma M&A
Lupin Ltd, India's third-largest drugmaker by sales, has agreed to acquire US-based pharmaceutical major GAVIS Pharmaceuticals LLC and Novel Laboratories ......
Healthcare
Cipla to divest stake in consumer healthcare business to Fidelity Growth Partners
Mumbai-based drugmaker Cipla Ltd is roping in Fidelity Growth Partners India, a PE unit of asset management giant Fidelity, as ......
Healthcare
Biocon to open IPO of R&D arm Syngene end of this month, fixes price band
Biopharmaceutical major Biocon Ltd has fixed the price band for the initial public offering (IPO) of its research and development ......
Healthcare
Sun Pharma share price crashes on Ranbaxy integration cost, sales alert
Shares of Sun Pharma plunged 15 per cent today, wiping out Rs 34,055.55 crore from its market valuation, after the ......
Healthcare
Lupin acquires Russian drug firm Biocom
Drug major Lupin today announced the acquisition of Russia's Biocom, marking its foray into the market which is expected to ......
Healthcare
Ascent Capital to swap stake in Alivira Animal Health with listed firm SeQuent Scientific
Home-grown private equity firm Ascent Capital will swap its stake in Alivira Animal Health Ltd with its public-listed parent, Bangalore-based ......
Healthcare
Marksans Pharma acquires New York-based Time-Cap Laboratories
Mumbai-headquartered Marksans Pharma Ltd has acquired Time-Cap Laboratories Inc, New York, according to a stock market disclosure. The deal amount ......